Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stratos Genomics is a biotechnology company that developed a groundbreaking DNA sequencing technology known as Sequencing by Expansion (SBX). This fourth-generation sequencing method utilizes a unique biochemical reaction to encode DNA sequences into highly measurable surrogate polymers called Xpandomers, which are then read by low-cost nanopore instruments. The technology is designed to provide fast, flexible, and cost-effective clinical diagnostic testing, significantly reducing sample preparation time compared to traditional methods. In May 2020, the company was acquired by Roche to advance the development of Roche's nanopore sequencer and personalized healthcare initiatives. Stratos Genomics continues to operate as a key innovation hub within Roche Diagnostics, focusing on high-throughput genomic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stratos Global.